PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 124 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $209,000 | -19.0% | 29,815 | +6.1% | 0.00% | -25.0% |
Q2 2021 | $258,000 | -31.2% | 28,105 | -27.1% | 0.00% | -33.3% |
Q1 2021 | $375,000 | -3.1% | 38,549 | +2.1% | 0.01% | 0.0% |
Q4 2020 | $387,000 | +4.0% | 37,748 | +2.4% | 0.01% | -14.3% |
Q3 2020 | $372,000 | +38.3% | 36,851 | +43.0% | 0.01% | +16.7% |
Q2 2020 | $269,000 | +86.8% | 25,769 | +51.4% | 0.01% | +50.0% |
Q1 2020 | $144,000 | +65.5% | 17,015 | +71.8% | 0.00% | +100.0% |
Q4 2019 | $87,000 | -14.7% | 9,905 | +4.0% | 0.00% | 0.0% |
Q3 2019 | $102,000 | +18.6% | 9,521 | +40.3% | 0.00% | 0.0% |
Q2 2019 | $86,000 | -65.7% | 6,784 | +4.7% | 0.00% | -66.7% |
Q1 2019 | $251,000 | +146.1% | 6,477 | +28.9% | 0.01% | +100.0% |
Q4 2018 | $102,000 | -52.1% | 5,023 | +7.9% | 0.00% | -40.0% |
Q3 2018 | $213,000 | +634.5% | 4,656 | +1832.0% | 0.01% | +400.0% |
Q3 2017 | $29,000 | +20.8% | 241 | -11.7% | 0.00% | 0.0% |
Q2 2017 | $24,000 | +50.0% | 273 | -35.5% | 0.00% | – |
Q1 2017 | $16,000 | – | 423 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,300,000 | $12,636,000 | 2.61% |
AIGH Capital Management LLC | 964,590 | $9,376,000 | 1.97% |
Worth Venture Partners, LLC | 226,758 | $2,204,000 | 1.07% |
Camber Capital Management LP | 2,555,000 | $24,835,000 | 0.85% |
Palo Alto Investors LP | 1,392,997 | $13,540,000 | 0.77% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,769,795 | $36,642,000 | 0.77% |
GLOBEFLEX CAPITAL L P | 428,680 | $4,167,000 | 0.76% |
Zebra Capital Management LLC | 34,243 | $333,000 | 0.37% |
Sofinnova Investments, Inc. | 344,917 | $3,353,000 | 0.20% |
RICE HALL JAMES & ASSOCIATES, LLC | 605,792 | $5,888,000 | 0.19% |